Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

UFS provides sign language skills to locals

2016-02-12

Description: UFS provides sign language skills to locals Tags: Sign language

Susan Lombaard teaching at one of the sessions
Photo: Valentino Ndaba

The public and private sectors are becoming more aware of the need for effective communication between employers, employees, and clients who use Sign Language. Given that Sign Language is the first language of approximately 600 000 people in South Africa, competence in the language means taking the first step towards more inclusive service delivery.

Shout Out Loud - a project that promotes Sign Language - has signed up Bloemfontein Celtics, Centlec, Beyond Boundaries, and the Mangaung Municipality on a Basic South African Sign Language course at the University of the Free State.

No miscommunication

Susan Lombaard, the Acting Head at the Department of South African Sign Language, was one of the lecturers who presented the 40-hour accredited course every Friday from 15 January-12 February 2016. Other lecturers who were responsible for training were Emily Matabane and Tshisikhawe Dzhivani.

Lombaard believes that learning Sign Language bridges the gap between the hearing and those who have impairments. “The benefit is that there will be no miscommunication. It happens that a deaf person walks into a bank or municipality offices and there is no communication. They need to write which is humiliating for that person.”

Towards a promising future

According to Goodwill Mokoena, Project Manager at Beyond Boundaries, the project will continue annually, and a larger intake of government departments and non-governmental organisations is expected in 2016.He also indicated that Shout Out Loud has achieved substantial success in its involvement with the Bartimea School for the Blind and Deaf.

Shout Out Loud selects one pupil every month, and flies them to Johannesburg to interpret on Bloemfontein Celtics’ magazine show. It is the only magazine show in South Africa that has a sign language interpreter. “The school has been achieving 100% in matric results because the pupils are selected on merit. This has enhanced their academic performance in such a marvelous way,” said Mokoena.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept